» Articles » PMID: 29861632

Airspace Dimension Assessment with Nanoparticles Reflects Lung Density As Quantified by MRI

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2018 Jun 5
PMID 29861632
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Airspace Dimension Assessment with inhaled nanoparticles is a novel method to determine distal airway morphology. This is the first empirical study using Airspace Dimension Assessment with nanoparticles (AiDA) to estimate distal airspace radius. The technology is relatively simple and potentially accessible in clinical outpatient settings.

Method: Nineteen never-smoking volunteers performed nanoparticle inhalation tests at multiple breath-hold times, and the difference in nanoparticle concentration of inhaled and exhaled gas was measured. An exponential decay curve was fitted to the concentration of recovered nanoparticles, and airspace dimensions were assessed from the half-life of the decay. Pulmonary tissue density was measured using magnetic resonance imaging (MRI).

Results: The distal airspace radius measured by AiDA correlated with lung tissue density as measured by MRI ( = -0.584; = 0.0086). The linear intercept of the logarithm of the exponential decay curve correlated with forced expiratory volume in one second (FEV) ( = 0.549; = 0.0149).

Conclusion: The AiDA method shows potential to be developed into a tool to assess conditions involving changes in distal airways, eg, emphysema. The intercept may reflect airway properties; this finding should be further investigated.

Citing Articles

Airspace Dimension Assessment with Nanoparticles (AiDA) in Comparison to Established Pulmonary Function Tests.

Petersson-Sjogren M, Jakobsson J, Aaltonen H, Nicklasson H, Rissler J, Engstrom G Int J Nanomedicine. 2022; 17:2777-2790.

PMID: 35782019 PMC: 9241766. DOI: 10.2147/IJN.S360271.


Airspace dimension assessment with nanoparticles as a proposed biomarker for emphysema.

Aaltonen H, Petersson Sjogren M, Jakobsson J, Nicklasson H, Diaz S, Sanchez Montiel F Thorax. 2021; 76(10):1040-1043.

PMID: 33859054 PMC: 8461447. DOI: 10.1136/thoraxjnl-2020-214523.


Airspace Dimension Assessment (AiDA) by inhaled nanoparticles: benchmarking with hyperpolarised Xe diffusion-weighted lung MRI.

Petersson-Sjogren M, Chan H, Collier G, Norquay G, Olsson L, Wollmer P Sci Rep. 2021; 11(1):4721.

PMID: 33633165 PMC: 7907057. DOI: 10.1038/s41598-021-83975-7.


Altered deposition of inhaled nanoparticles in subjects with chronic obstructive pulmonary disease.

Jakobsson J, Aaltonen H, Nicklasson H, Gudmundsson A, Rissler J, Wollmer P BMC Pulm Med. 2018; 18(1):129.

PMID: 30081885 PMC: 6080394. DOI: 10.1186/s12890-018-0697-2.

References
1.
Karimi R, Tornling G, Forsslund H, Mikko M, Wheelock A, Nyren S . Lung density on high resolution computer tomography (HRCT) reflects degree of inflammation in smokers. Respir Res. 2014; 15:23. PMC: 3944780. DOI: 10.1186/1465-9921-15-23. View

2.
Gould G, MacNee W, McLean A, Warren P, Redpath A, Best J . CT measurements of lung density in life can quantitate distal airspace enlargement--an essential defining feature of human emphysema. Am Rev Respir Dis. 1988; 137(2):380-92. DOI: 10.1164/ajrccm/137.2.380. View

3.
Robert H, Robert A, Kirk G, Drummond M, Mitzner W . Lung density changes with growth and inflation. Chest. 2015; 148(4):995-1002. PMC: 4594629. DOI: 10.1378/chest.15-0264. View

4.
Londahl J, Jakobsson J, Broday D, Aaltonen H, Wollmer P . Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?. Int J Nanomedicine. 2017; 12:41-51. PMC: 5191892. DOI: 10.2147/IJN.S121369. View

5.
Muller N, Staples C, Miller R, Abboud R . "Density mask". An objective method to quantitate emphysema using computed tomography. Chest. 1988; 94(4):782-7. DOI: 10.1378/chest.94.4.782. View